X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with RADICO KHAITAN - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs RADICO KHAITAN - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER RADICO KHAITAN GSK CONSUMER/
RADICO KHAITAN
 
P/E (TTM) x 41.8 35.8 116.9% View Chart
P/BV x 9.2 4.5 205.3% View Chart
Dividend Yield % 1.0 0.3 383.3%  

Financials

 GSK CONSUMER   RADICO KHAITAN
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
RADICO KHAITAN
Mar-18
GSK CONSUMER/
RADICO KHAITAN
5-Yr Chart
Click to enlarge
High Rs6,793418 1,625.0%   
Low Rs4,919107 4,596.7%   
Sales per share (Unadj.) Rs1,026.3136.7 750.6%  
Earnings per share (Unadj.) Rs166.59.3 1,790.0%  
Cash flow per share (Unadj.) Rs181.812.4 1,469.7%  
Dividends per share (Unadj.) Rs75.001.00 7,500.0%  
Dividend yield (eoy) %1.30.4 336.2%  
Book value per share (Unadj.) Rs828.686.8 954.8%  
Shares outstanding (eoy) m42.06133.31 31.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.71.9 297.2%   
Avg P/E ratio x35.228.2 124.6%  
P/CF ratio (eoy) x32.221.2 151.8%  
Price / Book Value ratio x7.13.0 233.6%  
Dividend payout %45.110.8 419.0%   
Avg Mkt Cap Rs m246,28434,994 703.8%   
No. of employees `0004.01.1 349.1%   
Total wages/salary Rs m5,2771,550 340.5%   
Avg. sales/employee Rs Th10,837.315,975.1 67.8%   
Avg. wages/employee Rs Th1,325.01,358.2 97.6%   
Avg. net profit/employee Rs Th1,757.71,086.5 161.8%   
INCOME DATA
Net Sales Rs m43,16518,228 236.8%  
Other income Rs m2,574267 965.2%   
Total revenues Rs m45,73918,494 247.3%   
Gross profit Rs m8,8342,698 327.5%  
Depreciation Rs m644409 157.4%   
Interest Rs m20682 3.0%   
Profit before tax Rs m10,7441,873 573.7%   
Minority Interest Rs m05 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,743638 586.4%   
Profit after tax Rs m7,0011,240 564.8%  
Gross profit margin %20.514.8 138.3%  
Effective tax rate %34.834.1 102.2%   
Net profit margin %16.26.8 238.5%  
BALANCE SHEET DATA
Current assets Rs m45,62012,389 368.2%   
Current liabilities Rs m17,4269,513 183.2%   
Net working cap to sales %65.315.8 413.9%  
Current ratio x2.61.3 201.0%  
Inventory Days Days3562 55.6%  
Debtors Days Days24126 18.7%  
Net fixed assets Rs m5,1387,057 72.8%   
Share capital Rs m421267 157.8%   
"Free" reserves Rs m34,43111,302 304.6%   
Net worth Rs m34,85111,569 301.3%   
Long term debt Rs m0344 0.0%   
Total assets Rs m54,12722,459 241.0%  
Interest coverage x530.23.7 14,160.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 98.3%   
Return on assets %13.08.6 151.6%  
Return on equity %20.110.7 187.5%  
Return on capital %30.921.5 143.7%  
Exports to sales %06.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,153 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,0141,153 261.4%   
Fx outflow Rs m1860-   
Net fx Rs m2,8281,153 245.3%   
CASH FLOW
From Operations Rs m7,2303,163 228.6%  
From Investments Rs m-4,465-213 2,099.0%  
From Financial Activity Rs m-3,634-2,926 124.2%  
Net Cashflow Rs m-86825 -3,543.3%  

Share Holding

Indian Promoters % 0.0 40.5 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 9.4 8.5%  
FIIs % 12.0 19.6 61.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 30.5 48.5%  
Shareholders   26,457 37,115 71.3%  
Pledged promoter(s) holding % 0.0 22.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   REI AGRO LTD.  KRBL LIMITED  DABUR  UNITED BREWERIES  TILAKNAGAR IND.  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

RADICO KHAITAN Announces Quarterly Results (1QFY19); Net Profit Up 84.4% (Quarterly Result Update)

Jul 25, 2018 | Updated on Jul 25, 2018

For the quarter ended June 2018, RADICO KHAITAN has posted a net profit of Rs 474 m (up 84.4% YoY). Sales on the other hand came in at Rs 21 bn (up 53.8% YoY). Read on for a complete analysis of RADICO KHAITAN's quarterly results.

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

ITC: GST Cess Weighs on Cigarettes (Quarterly Results Update - Detailed)

Nov 7, 2017

Additional cess in the GST regime hurts ITC's cigarette business.

GSK CONSUMER Announces Quarterly Results (4QFY18); Net Profit Up 20.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 20.4% YoY). Sales on the other hand came in at Rs 12 bn (down 2.4% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Sep 21, 2018 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - ADVANTA LTD. COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS